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Interpretation of Male Rat Renal Tubule
Tumors
by Imogene Sevin Rodgers12 and Karl P. Baetcke'
Based on an analysis of recent scientific studies, a Technical Panel ofthe U.S. Environmental Protection
Agency's (EPA) Risk Assessment Forum recently advised EPA risk assessors against using information on
certain male rat renal tubule tumors to assess human risk under conditions specified in a new Forum report.
Risk assessment approaches generally assume that chemicals producing tumors in laboratory animals are a
potential cancerhazardtohumans.Formostchemicals, includingclassical rodentkidneycarcinogens suchas
N-ethyl-N-hydroxyethylnitrosamine, this extrapolation remains appropriate. Some chemicals, however,
induce accumulation ofct2,-globulin(%.-g), a low molecular weight protein, in the male rat kidney. Thea2.-g
accumulation initiates asequence ofevents thatappears to leadto renal tubuletumorformation. Female rats
and other laboratory mammals administered the same chemicals do not accumulate low molecular weight
protein in the kidney, and they do not develop renal tubule tumors. Because humans appear to be more like
other laboratory animals than like the male rat, in this special situation, the male rat is not a good model for
assessing human risk. The Forum report stresses the need for full scrutiny of a substantial set of data to
determinewhenitisreasonable topresumethatrenaltumorsin maleratsarelinkedtoaprocessinvolvinga2u-
g accumulation and to select appropriate procedures for estimating human risks under such circumstances.
Introduction
EPA's Risk Assessment Forum is composed of a group
of EPA scientists selected for their expertise in various
areasofriskassessment. TheForumstudiescontroversial
risk assessment issues and promotes scientiflc consensus
within EPA ontheseissues. Formajorprojects,theForum
formally convenes a Technical Panel of EPA scientists to
report on the issues from an Agencywide perspective.
To examine the issue ofchemically induced a2u-globulin
(a2u-g)accumulationanditsrelationtorenaltubuletumors
in the male rat, in 1987 the Forum formed a Technical
Panel chaired by Karl Baetcke ofthe Office of Pesticides
Programs. Other members of the Technical Panel were
Letitia Tahan, co-chair, and Marion Copley, Julie Du,
Robert McGaughy, William Pepelko, Cheryl Siegel Scott,
and Lawrence Valcovic. Gordon Hard, avisitingprofessor
at the Medical Research Council, was a consultant to the
project. The Forum's Technical Panel recently completed
its review ofthe issue and made recommendations to EPA
for the evaluation of renal tubule tumors in the male rat.
This article for the International Symposium on the
HealthEffects ofGasolinehighlightstheTechnicalPanel's
findings, which are described in detail in the RiskAssess-
ment Forum report (1).
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A variety of organic chemicals have produced specific
renal lesions in male rats in the form ofa hyaline droplet
nephropathy accompanied by accumulation ofthe protein
x2u-g (2-12). The Technical Panel's analysis focused on
compounds with both an adequate animal carcinogenesis
bioassay and information on ca2u-g or hyaline droplet
accumulation in the male rat as follows: 1,4-dichloro-
benzene, dimethylmethylphosphonate, hexachloroethane,
isophorone, d-limonene, pentachloroethane, tetrachloro-
ethylene, and unleaded gasoline. The analysis also relied
onresearch studies on decalin and2,2,4-trimethylpentane
(a significant component ofgasoline) because both chemi-
cals have extensive information on U2u-g nephropathy but
no chronic bioassay data.
It is clear that not all renal tubule cancer in laboratory
animals occurs through the hypothesized a2u-g sequence.
Other inducers of rodent renal tubule cancer are well
known. These include, for example, certain nitrosamines
in the rat and mouse and diethylstilbestrol in hamsters
(13,14). Thus, anyprocedure thattreatsa2u-ginducers in a
mannerdifferentfrom classicalrenal carcinogens mustbe
able to distinguish the two processes.
Recommendations of the Forum
Technical Panel
The Risk Assessment Forum Technical Panel recom-
mended that EPAs risk assessors apply the following
science policy for evaluation of male rat renal effects
arising as a result ofthe progression oflesions beginningRODGERS AND BAETCKE
with chemicallyinduced x2u-gaccumulation. Forpurposes
ofhuman risk assessment, male rat renal tumors arising
as the result of other processes would continue to be
evaluated by conventional procedures described in EPA's
guidelines (15). Male rat renal tubule tumors arising as a
result ofa process involvingU2u-g accumulation would not
contribute to theweight ofevidence that a chemical poses
a human carcinogenic hazard. Such tumors would not be
included in dose-response extrapolations for the estima-
tion of human carcinogenic risk. The associated t2u-g
nephropathy would not be used to determine noncar-
cinogenic hazard. Estimates of noncarcinogenic risk
would be based on other end points.
Even when chemically induced kidney tumors in the
male rat areclearlya-2u-g-related, othertumorsinexposed
laboratory animals may be important in evaluating the
carcinogenicpotential ofthechemical. However, theroleof
chemically induced t2u-g accumulation in the induction of
renal tubule tumors in the male rat would be assessed
independently of evaluations made regarding tumors at
other sites.
Basis for the Technical Panel's
Recommendations
The information thatfollows highlights critical dataand
outlines inferential bridges used bythe Technical Panel to
select the most plausible explanation for the information
available on male rat kidney tumors.
Low Molecular Weight Proteins in the Rat
In rat kidneys, as in those ofother mammals, naturally
occurring low molecular weight proteins are transferred
from the plasma into the urine by glomerular filtration.
The proteins are then partially reabsorbed from the urine
into the renal tubule of the kidney, where they are even-
tuallybroken down bycatabolism (16,17). One ofthese low
molecular weight proteins, a2u-g, produced by the liver
under the stimulus of testosterone, reaches very high
levels in the plasma and urine of young adult male rats,
gradually declining with age (18-20).
cx2u-Globulin is regarded as a member of alarge super-
family of proteins thought to be carriers of lipophilic
molecules (21, 22). Some of these proteins, e.g., retinol-
binding protein and o1-acid glycoprotein, are found in
manyspecies,includinghumans (23,24). Others, likeot2u-g,
are species specific. The only member ofthe superfamily
with a clearly defined physiological role is retinol-binding
protein, the carrier protein for vitamin A (22). Although
these low molecular weight proteins are believed to have
similar three-dimensional structures (25), the alignment
ofamino acid residues between anypair ofproteins in the
superfamily is small, roughly 20% (21). The exception is
x-2u-g and mouse major urinary protein(s) (MUP), which
are approximately 90% homologous (26).
cx2u-Globulin derived from hepatic synthesis is not
known to occur in the female rat or any other species (27-
29),includinghumans.Although similarforms ofa2u-gare
synthesized at nonhepatic sites in female rats and in the
male National Cancer Institute (NCI) Black Reiter (NBR)
rat (30), astrainwhosemales lackhepatic synthesis of x2L,-g
(31), none ofthese otherforms ofcX21-gnorMUP appears to
accumulate in the renal tubule after administration of the
eight model carcinogens examined by the Technical Panel.
Progression from Chemically Inducedca2u-
Globulin Accumulation to Nephropathy and
Neoplasia
The sequence ofevents occurring in themale ratkidney
after administration of chemicals inducing cx2u-g
accumulation (CIGA) can be portrayed on a cellular and
molecularlevel. Initially, the test chemical appears to bind
reversibly to cx2u-g, seemingly forming a complex more
resistant to lysosomal degradation than the unreacted
protein itself (32,33). This shifts the balance between
reabsorption and catabolism and appears to result in
accumulation of the protein complex in a specific area of
the renal tubule, the P2 segment. Continued compound
administration results in a cytotoxic response from the
sustained protein overload to the renal tubule, causing
single-cell necrosis ofcells liningthe surface ofthe tubule
and other kidney pathology (34,35). The dead cells are
replaced by cell division. As the cycle ofcell death and cell
replacement continues, with time, tubule hyperplasia and
neoplasia may occur. It is presumed, but certainly not
proven, that continued cell proliferation plays a role in the
neoplastic process.
Morphologically, the sequence of events begins with an
excessive accumulation ofhyaline droplets containing Q2u-g
intherenalproximaltubules(36-38).Thenextcharacteristic
lesion, single-cell necrosis in the renal tubule, can be con-
firmed by observation of exfoliated, degenerate cells in the
tubule lumen and granular casts (2,40). Enhanced cell rep-
licationinresponsetocelldeathcanbeseenasincreasedcell
division or demonstrated by labeling techniques that mea-
sureincreased DNAsynthesis (34,35,41,42). In chronic labo-
ratory animal bioassays, tubule hyperplasia (43-45), linear
mineralization in the renal papilla (possibly representing
remnants of debris from disintegrating granular casts)
(2,40), and renal tubule tumors (43-51) are observed.
Specificity ofthe Sequence to the Male Rat
The consistent results from hypothesis-testing experi-
ments conducted in various laboratories support the con-
clusion that accumulation ofabnormal amounts of x2u-gin
the P2 segment of the renal tubules can cause a charac-
teristic nephropathy in the male rat. The severity of this
kidney disease is dose dependent, not onlywith respect to
the amount of compound administered but also with
respectto the concentration of 2X2u-ginthekidney(53-55).
This cx2u-g-induced nephropathy differs sufficiently from
chronic progressive nephropathy commonly found spon-
taneouslyin agingmale rats so thatthe two effects can be
distinguished (57). In contrast, mice and female rats
administereda2.-ginducers underthe same conditions as
male rats did not develop lesions characteristic ofct2u-g
nephropathy (45).
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Hyaline droplets in the proximal tubule of untreated
male rats contain ot2u-g, especially in young adults
(2,30,58). Hyaline droplets are substantially reduced in
castrated male rats, further demonstrating the depen-
dence of this phenomenon on male hormone levels. In
female rats of any age, protein droplet formation is rare,
and a2u,-g is not present in the droplets.
Specialized studies involving hormone manipulation
have shown that the development ofthe early features of
ot2u-gnephropathydepends on the presence ofthehepatic
form ofa2u-g. Hyaline droplet orot2u-g accumulation does
not occurwhen x2u-g inducers are administered to imma-
ture or old male rats that produce little oa2u-g in the liver
(2,30). Hyaline droplet accumulation is observed from
administration ofa2u-ginducersevenincastratedrats,but
the severity of the effect is diminished (59). Estrogen
administration to male rats reduces the severity ofat2u-g
nephropathy (60). Female rats administered an ax2u-g
inducer along with at2u-g purified from male rat urine
clearly showed hyaline dropletformation, (x2u-gaccumula-
tion in the kidney, and some nephropathy even though
control female rats showed no measurable effects (61).
The specificity ofthemale ratresponse has been tested
to a limited extent in a number of other species, with no
evidence of hyaline droplet nephropathy in dogs, guinea
pigs, hamsters, ormonkeys (2,10,38,62-65). Because these
species (and the mouse and female rat) have proteins
similar in structure to a2u-g, the lack of damage to their
kidney cells is consistent with the presumption that the
specific x2u-g produced by the liver ofmale rats is neces-
sary for the expression ofthe renal effects.
Male rats of the NBR strain provide a unique oppor-
tunityfortestingthe x2u-ghypothesisbecausethisanimal
hasnodetectablelevelsofhepaticmessengerRNAfora2ug-
Underconditions ofexposure thatproducedo2u-gnephro-
pathy in male rats of other strains, several chemicals
administered to the NBR rat did not induce detectable
accumulation ofU2,-g in the renal tubules (66,67).
Mice and female rats exposed to ot2u-g inducers in
chronicbioassays did notdevelop anincreasedincidence of
renal tubule tumors (43-52). In contrast, male rats devel-
oped a dose-dependent neoplastic response in the kidney.
Additional experimentation using a nitrosamine as the
initiator of cancer and an X2u-g inducer as the promoter
also support the observation that a2u-g is involved in the
process leading to renal tubule tumors in the male rat
(68,69). In one ofthese studies, the promotion potential of
an 2t2u-g inducer in NBR rats was contrasted with the
response in aconventional strain, the F344 rat. Consistent
with the hypothesis that cx2u-g is necessary to induce a
response, thepromoterdidnotenhancerenaltubuletumor
formation in the a2u-g-deficient NBR rat, but it did pro-
mote renal tubule tumor formation in the F344 rat (68).
Distribution studies of compounds and information on
chemical binding toa2u-gindicate that, ofthe total chemi-
cal administered to the animal, only a small portion ofthe
metabolites (possibly the parent compound) can account
for all of the a2u-g accumulation (70-73). Considerable
amounts ofthechemical andothermetabolitesmayalsobe
present in the male rat kidney, not bound to c2u-g. These
other moieties may, at times, cause toxic effects in the
kidney, possibly even cancer, that are unrelated to the
accumulation ofU2u-g. Such information does notpreclude
adeterminationthatthea2,-gsequenceisinvolvedinsome
manner with the renal tumor response.
ot2u-Globulin Inducers and Other Renal
Carcinogens
It is instructive to compare CIGA renal carcinogens
with other renal carcinogens. Several genotoxic chemicals
recognized as classical inducers of rodent kidney tumors
have been used to study the pathogenesis ofrenal tubule
cancer in laboratory animals (13,14,74). In general, these
prototypic renal carcinogens produce tumors in both
males and females. Although the wide range ofchemicals
represented suggests multiple mechanisms of action,
many of the classical renal carcinogens or their active
metabolites are electrophilic species able to bind
covalently to macromolecules and likely to form DNA
adducts in the kidney. In contrast, CIGA renal carcino-
gens are not known to react with DNA (75) and are
generally negative in short-term tests for genotoxicity
(76-81). CIGArenalcarcinogensalsointeractwitha2u-gin
a reversible and noncovalent manner (71-73).
Classical renal carcinogens, such as certain nitro-
samines, induce renal tubule cancer in rats or mice with
high incidence, minimal duration of exposure, and clear
dose-response relationships (82). In contrast, the renal
tumors produced by the eight model carcinogens exam-
ined bythe Technical Panel tended not to be life threaten-
ing, occurred late in life, were usually found at terminal
sacrifice, and were frequently microscopic. Even though
the maximum-tolerated dosewas exceeded for some ofthe
eight model carcinogens, the renal tumor incidence rate,
adjusted for intercurrent mortality, was never greater
than 28%. An increase in renal tubule tumors was not
found in mice or female rats exposed to these chemicals.
Such differences in potency and species-, strain-, and sex-
susceptibilitysuggestthatCIGArenalcarcinogens actvia
different mechanisms from classical renal carcinogens.
Renal tubule tumors produced by CIGA carcinogens
also have features in common with other renal tubule
tumors observed inthemale rat. Forrenal carcinogens, in
general, there is a continuum ofchemically induced steps
from atypical hyperplasia through microscopic adenomas
tomacroscopicadenocarcinomas orcarcinomas(13). Renal
tubule tumors induced bythe eightmodel carcinogens are
morphologically indistinguishable from those induced by
classical carcinogens. Likewise, the sequence of develop-
ment of CIGA carcinogen-induced renal tumors from
tubule cell hyperplasia to carcinoma appears identical.
Furthermore, none of these chemically induced tumors
can be differentiated from spontaneous tumors.
Epidemiologic Studies
TheTechnical Panelwas notaware ofanyepidemiologic
study that has been designed or conducted specifically to
examine the applicability ofthe CIGAhypothesis to renal
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cell cancer in humans. Several epidemiologic studies were
reviewed (83-91), but they are of limited value for this
analysisbecausetheyinvolved exposuretocomplexblends,
such as gasoline, or otherwise involved multiple exposures
to both CIGA and nonCIGA. In addition, these studies
were of limited statistical power and were not able to
account forpossibly confounding factors, such as smoking
or obesity, which are known to influence renal cell cancer
rates. In afew studies, slight increases in risk ofrenal cell
cancer have been observed; however, the other factors
described above could have easily accounted for the
increased risk. These studies, therefore, are considered
inadequate for purposes ofexploring the relevance ofthe
t2u-ghypothesis in humans.
Conclusions
Based on the preceding analysis, the Technical Panel
reached three major conclusions. First, the sequence of
eventsproposedtolinkac2u-gaccumulationtonephropathy
and renal tubule tumors in the male rat is plausible,
although not totally proven.
Second, the x2u-g response following chemical admin-
istration appearstobeuniquetothemalerat.Eventhough
closely related proteins are present in other species, there
is noevidence thatthese speciesrespond toa2u-ginducers
in a manner similar to the male rat.
Third, the male rat kidney response to chemicals that
induce a-2u-g accumulation is probably not relevant to
humans. This, ofcourse, does notmean that all chemically
induced renal tubule tumors in the male rat are at2u-g
associated.
Guidance for Evaluating Chemically
Induced Male Rat Renal Tubule
Tumors
The Risk Assessment Forum Technical Panel recom-
mended the following guidance to EPArisk assessors for
evaluation ofrenal tubule tumors. This guidance is based
onthepresumptionthattherearesufficientdata(e.g., two-
year bioassay in rats and mice, evidence to judge the
genotoxicity of the chemical, information on a22u-g
accumulation and other toxicity, and information on the
compound'spotential to cause sustained cellproliferation).
Ifthese data are notavailable, the tumors are evaluated in
accordance with standard procedures, not those specified
for CIGA.
Chemicals inducing renal tubule tumors in the male rat
would be placed in one ofthe following categories: a) the
cx2u-g sequence ofevents accounts for the renal tumors, b)
other potential carcinogenic processes account for the
renal tumors, c) the a2u-g-associated events occur in the
presence ofotherpotentialcarcinogenicprocesses,both of
which result in renal tumors.
Evaluation of the data to determine which category
applies would be a two-step process. First, the available
information would be examined to determine whether the
'a2u-g process is involved in the tumor development. Ifthe
data do not support such an association, then the male rat
renal tubule tumors would be used conventionally for
characterizing human risk, and no further evaluation of
therole ofat2-gaccumulationwouldbepossible orneeded.
Renal Tubule Tumors in Male Rats and
ot2u-GlobulinAccumulation
The following information from adequately conducted
studiesofmaleratsshowsthattheU2u-gprocesscouldbea
factor in the observed renal effects; affirmation of chem-
ically induced a2u-g involvement in each of the three
categories is necessary.
Increased Number and Size ofHyaline Droplets in
RenalProximal Tubule Cells ofIreatedMaleRats. The
abnormal accumulation ofhyaline droplets in the P2 seg-
mentofthe renaltubule is necessaryto attributetherenal
tubuletumors totheU2u-gsequence ofevents.Thisfinding
helps differentiate a2u-g inducers from chemicals that
produce renal tubule tumors through other means.
The Protein Accumulating in the Hyaline Droplets
is oL2u-g. Hyaline droplet accumulation is a nonspecific
response to protein overload in the renal tubule and may
not be due to Ux2u-g [e.g., as with chlorothalonil (66)].
Therefore, it is necessary to demonstrate that o2,1-g
accounts for the hyaline droplet accumulation found in the
male rat.
Additional Aspects ofthe Pathological Sequence of
Lesions Associated with oX2u-g Nephropathy Are Pre-
sent. Typicallesionsincludesingle-cellnecrosis,exfoliation
ofepithelial cells into the proximal tubular lumen, forma-
tion of granular casts, linear mineralization of papillary
tubules, and tubule hyperplasia. Ifthe response ismild, all
of these lesions may not be observed; however, some
elements consistent with the pathological sequence must
be demonstrated to be present. In the absence of this
minimum information, there is no basis for judging the
applicability ofthea2u-gprocess, and itwould be assumed
that the male rat renal tumors are relevant for risk
assessment purposes.
Additional Information Useful for the
Analysis
If the x2u-g process appears to be a factor in the
observed renal effects, then otherinformation isuseful for
determining whether the renal effects are solely c2u-g-
associated, a combination of the a2u-g process and other
potential carcinogenic processes, or due primarily to other
processes. Some types ofusefulinformation arelistedbelow.
Hypothesis-Testing Data. Data from specialized tests
greatly increase confidence that the at2u-g sequence is
involvedintherenaltubuletumorresponse. Suchinforma-
tion might include: modification of the nephrotoxic
response through use ofthe NBR rat, or manipulation of
sex hormones (e.g., androgens), or c2u-g levels (e.g., t2u-g
administration to female rats). Other information might
include initiation-promotion studies comparing males of
the NBR strain with males of other rat strains.
Additional Biochemical Information. Certain in vivo
and in vitro data help characterize a chemical as one that
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induces accumulation of a2u-g. Such information might
include reversible binding ofthe chemical (ormetabolites)
to x2u-g, reductioninthelysosomal degradation ofthea2u-g
complex, and disposition studies demonstrating sex- and
species-specific retention ofthe testcompound inthemale
rat kidney.
Sustained Cell Division in Proximal Tubule of the
MaleRat. Asustainedincreaseincellreplication intheP2
segment of the renal tubule at doses used in the cancer
bioassay and a dose-related increase in atypical hyper-
plasia of the renal tubule is consistent with the ct2u-g
process, especially iflaboratory animals in addition to the
maleratweretestedanddidnotrespond.Theseendpoints
are nonspecific for t2u-ginducers, however, because other
renal carcinogens may also affect the P2 segment of the
renal tubule.
Structure-Activity Relationship. Structure-activity
relationships forchemicals thatinduce ux2u-g accumulation
in the male rat kidney are notwell defined, although there
appear to be dimensional requirements to fit the protein
pocket, a requirement for a degree of lipophilicity, and a
need for an electronegative atom in the molecule or its
active metabolite (92). Other structural features might
suggest that a chemical belongs to a different class of
suspected carcinogens.
Covalent Binding to Macromolecules. Some classical
inducers of renal tubule cancer are known to bind
covalentlytoDNA. BecauseCIGAdo notappeartobindto
DNA, such information may assist in distinguishing
between the different processes leading to renal cancer.
Genotoxicity. ct2u-Globulin inducers have been non-
genotoxic, and they do not depend on direct genetic injury
for the production oftumors. Thus, information on poten-
tial genotoxicity in a standard battery ofshort-term tests
relevant to the evaluation of potential carcinogenicity
helps distinguish them from other renal carcinogens.
Nephrotoxicity. Chronic progressive nephropathy
(CPN) inthe agingmale rat can complicate the analysis of
other renal lesions. However, nephrotoxicity in the male
rat not attributable to either CPN or a2u-g accumulation,
or a nephrotoxic response in the female rat or the mouse,
suggests thatthepossibility ofotherprocesses leading to
renal cancer should be considered.
Animal Bioassay Data in Other Species and Sex-
Combinations. The x2u-gsyndromeis specific to themale
rat. Positive cancer responses intherenaltubuleinfemale
rats, mice of either sex, or any other laboratory animal
implythattheQ2u-gsyndromealonecannotaccountforthe
renal tubule tumor response in-the male rats.
Confidenceindeterminingwhichofthethreecategories
applies depends on the comprehensiveness and consis-
tencyofavailable data. Decisions ontheapplicabilityofthe
three categories described above can only be made on a
case-by-case basis, taking all of the information into
account.
Use ofthe Data for Risk Assessment
Once a decision on the applicability ofthe three catego-
riesismade,itispossible todeterminehowtheresponsein
the male rat renal tubule would apply to evaluation of
human hazard and to estimation of human cancer risk.
TheTechnical Panelrecommended thefollowingguidance,
recognizingthattumors occurring atothersitesinlabora-
tory animals administered compounds that induce cx2u-g
accumulation in the male rat will be judged on their own
merits.
a) Renal tubule tumors in male rats attributable solely
to chemically-induced ot2u-g accumulation would not be
used for human cancer hazard identification or for dose-
response extrapolations. b) Renal tubule tumors that are
not linked toa2,-g accumulation would be appropriate for
humanhazardidentification, andtheywouldbeconsidered
along with other appropriate end points for quantitative
risk estimation. c) In general, the information needed to
make aquantitative determination oftherelative contribu-
tion ofcompounds producing some renal tubule tumors in
male rats attributable to the a2u-g process and some
attributable to other carcinogenic processes will not be
available. If there is enough information, however, the
non-ao2u-g-induced component may be used, as appropri-
ate, for dose-response evaluation aswell as hazard identi-
fication. Usually, suchinformationisnotavailable,inwhich
case ameaningful dose-response estimate based on renal
tubuletumors inthemaleratisnotpossibleand shouldnot
be performed; thenon-u2u-g-induced renal tubule tumors
remain relevant for purposes ofhazard identification.
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